ZZSW-01

N/A

Report date: 2026/05/12 09:17:00

Base Information

Drug NameZZSW-01
Drug Alias NameZZSW-01
ClassificationCell and gene therapy > Cell therapy > In vivo cell therapyCell and gene therapy > Gene therapy > mRNACell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy +[4] 
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Union Hospital
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Union Hospital
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A